bioMérieux launches an avian flu test for research purposes


bioMérieux confirmed its commitment to the fight against emerging diseases and launched its avian flu detection test. Developed to respond to the needs of reference laboratories involved in the identification of the disease and in the fight against avian flu, the test, called NucliSens EasyQ® Influenza H5 and N1 is a kit of reagents exclusively for research purposes. It can detect the presence of both the H5 and N1 genetic targets in 90 minutes and will be used with the bioMérieux's NucliSens® range of molecular biology systems.

Other news from the department research and development

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics